JOHANNESBURG, Jan 21 (Reuters) – South African pharmaceutical company Biovac Institute has been contracted by the government to import, store and distribute coronavirus vaccines for frontline healthcare workers, a letter from the National Treasury shows.
Healthcare experts have urged the government to share a detailed plan on vaccine rollout across the country.
In the letter written by Director-General Dondo Mogajane to non-profit organisation Corruption Watch (CW) and seen by Reuters, Treasury has given the Department of Health approval to deviate from normal procurement processes for the transportation, storage and distribution of the vaccines in the short term.
The National Treasury and spokespeople for the Department of Health did not respond to requests for comment.
Cape Town-based Biovac, part owned by the government, has been appointed for three months to provide storage and distribution services for vaccines to immunise frontline healthcare workers, the letter showed.
“Biovac will be involved in the importation, cold chain storage and distribution of the 1.5 million doses,” Biovac CEO Morena Makhoana told Reuters.
South Africa has said it will receive 1.5 million doses of AstraZeneca’s COVID-19 shot from the Serum Institute of India (SII), spread over January and February.
Regarding storage and distribute of vaccines in the medium term – over a period of six months – the letter said the government is approaching Imperial Logistics’ Health Sciences unit, Denmark’s DSV Panalpina, pharmacy chain Clicks Group’s United Pharmaceutical Distributors (UPD) and Biovac in a closed bidding process.
Asked about this, DSV said it could not comment outside of its closed period, Clicks referred questions to the Department of Health and Imperial was not immediately available for comment.
The Treasury’s Mogajane was responding to CW’s Executive Director David Lewis who had written to the Treasury seeking clarity regarding emergency procurement and rollout of vaccines.
Mogajane noted that the Auditor-General would be asked at the appropriate time to conduct real-time audits of the vaccines procurement process.
“CW is pleased that the Auditor-General will be involved in oversight of the use of public money for vaccine procurement,” the non-profit CW said in a statement on Thursday. (Reporting by Nqobile Dludla and Wendell Roelf; editing by Promit Mukherjee and Jason Neely)
(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html